Why Compare 5mg Mounjaro to Wegovy Side-by-Side?
Understanding the 5mg Mounjaro to Wegovy Transition Decision
When evaluating 5mg Mounjaro to Wegovy, the fundamental difference lies in their active ingredients and receptor targets. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This mechanistic distinction means the medications work through different pathways to support appetite regulation and weight management alongside a reduced-calorie diet and increased physical activity. Patients considering the switch from 5mg Mounjaro to Wegovy often want to understand how the dosing schedules compare, with Wegovy following a structured 5-dose escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro progresses through 6 doses from 2.5mg to 15mg maximum.
The decision between these prescription-only medicines isn't simply about comparing 5mg Mounjaro to Wegovy doses directly, as the medications have different potencies and dose equivalencies. Your prescriber will consider factors including your response to current treatment, any side effects experienced, storage preferences, and long-term treatment goals when evaluating whether transitioning from 5mg Mounjaro to Wegovy makes clinical sense. Both medications require careful dose escalation to minimise gastrointestinal side effects, and switching between them typically involves a washout period and fresh titration schedule. EverydayMeds stocks both options, ensuring continuity of supply whichever treatment path your healthcare provider recommends for your individual circumstances.
Wegovy vs Mounjaro Pricing and Value Comparison
Understanding the cost implications when considering 5mg Mounjaro to Wegovy requires examining both medications' complete dose escalation journeys. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), £99.99 for 1mg (weeks 9-12), £139.99 for 1.7mg (weeks 13-16), and £209.99 for the 2.4mg maintenance dose from week 17 onwards. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. For those requiring extended treatment at specific doses, our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, covering your first 12 weeks of treatment.
When weighing 5mg Mounjaro to Wegovy costs, consider that Mounjaro's 5mg dose typically represents a mid-stage treatment level, whilst Wegovy's dosing follows a different progression entirely. The Ultimate Stability Trio provides three months of Wegovy maintenance dose (2.4mg x3) for £649.99, ensuring uninterrupted supply once you've completed dose escalation. Our bundles offer convenience rather than just savings - fewer orders to place, Reliable Supply continuity, and single delivery logistics. Both medications require ongoing treatment to maintain weight management benefits, so evaluating long-term costs alongside clinical suitability helps inform the 5mg Mounjaro to Wegovy decision-making process with your prescriber.
Clinical Evidence Supporting 5mg Mounjaro to Wegovy Decisions
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in weight management when used alongside lifestyle interventions. In the landmark STEP 1 trial, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 extension study demonstrated sustained weight loss of approximately 15.2% at 2 years, supporting long-term treatment approaches. These trials enrolled participants with BMI ≥30 or BMI ≥27 with weight-related comorbidities, matching the current MHRA-licensed indication for prescription in the UK.
When considering 5mg Mounjaro to Wegovy transitions, both medications have demonstrated cardiovascular benefits in their respective clinical programmes. Wegovy's SELECT trial showed a 20% reduction in major cardiovascular events (hazard ratio 0.80) in adults with established cardiovascular disease and overweight or obesity. However, directly comparing trial results between semaglutide and tirzepatide studies isn't appropriate due to different trial designs, patient populations, and endpoint definitions. Your prescriber will evaluate your individual response history, tolerability profile, and clinical goals when assessing whether switching from 5mg Mounjaro to Wegovy aligns with evidence-based treatment optimisation.
How Wegovy's GLP-1 Mechanism Differs in the 5mg Mounjaro to Wegovy Context
Wegovy works as a GLP-1 receptor agonist, binding to receptors primarily located in the brain's appetite control centres, pancreas, and digestive system. When you inject Wegovy weekly, the semaglutide mimics your natural GLP-1 hormone, sending satiety signals that may help reduce food intake and promote feelings of fullness after smaller meals. This mechanism also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. The medication may reduce food cravings by acting on neural pathways in the hypothalamus and other brain regions involved in appetite regulation and food reward. Unlike dual-receptor approaches, Wegovy's singular focus on GLP-1 pathways provides targeted intervention that has been extensively studied across multiple clinical trials. For patients transitioning from 5mg Mounjaro to Wegovy, this represents a shift from dual-hormone mimicry to focused GLP-1 activation, which your prescriber will monitor carefully during the changeover period.
Streamlined Ordering Process for 5mg Mounjaro to Wegovy Comparisons
Beginning your 5mg Mounjaro to Wegovy evaluation starts with our 3-minute online clinical assessment, designed to capture your medical history, current medications, and treatment goals comprehensively. Our qualified prescribers review every application thoroughly, with standard review completed within 3 working days or express 24-hour service available for urgent requirements. The assessment covers your experience with current weight management treatments, any side effects or tolerability issues, and specific factors that might influence the choice between continuing Mounjaro or transitioning to Wegovy. Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled cold-chain logistics to preserve medication integrity. Our GPhC registered pharmacy (#9012878) ensures every Wegovy pen meets pharmaceutical standards, with batch tracking and expiry date monitoring throughout the supply chain. Whether you're ordering your first Wegovy prescription or managing an ongoing transition from 5mg Mounjaro to Wegovy, our clinical team provides ongoing support throughout your treatment journey.
Storage Advantages When Considering 5mg Mounjaro to Wegovy
Wegovy offers significant practical advantages in storage flexibility compared to Mounjaro, which can influence your 5mg Mounjaro to Wegovy decision-making process. While both medications require refrigeration at 2-8°C before first use, Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more suitable for travel, business trips, or situations where consistent refrigeration access might be challenging. The FlexTouch pen design provides intuitive injection with clear dose windows and audible dose completion clicks, ensuring accurate administration throughout the dose escalation schedule from 0.25mg starter to 2.4mg maintenance. Each pre-filled pen contains 4 doses, delivered weekly, with needle replacement required for each injection to maintain sterility and injection comfort. For patients switching from 5mg Mounjaro to Wegovy, this storage convenience often represents a welcome practical improvement alongside the clinical benefits of semaglutide therapy.
Dose Escalation Strategy for 5mg Mounjaro to Wegovy Transitions
Transitioning from 5mg Mounjaro to Wegovy requires careful consideration of dose equivalencies and escalation timing, as these medications don't have directly comparable dose conversions. Wegovy follows a mandatory escalation schedule starting at 0.25mg weekly for 4 weeks, then 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, before reaching the 2.4mg maintenance dose from week 17 onwards. Your prescriber may recommend a washout period between stopping Mounjaro and starting Wegovy to prevent overlapping effects and accurately assess your response to the new treatment. The 5mg Mounjaro dose represents a mid-level treatment stage in tirzepatide therapy, but Wegovy's semaglutide requires fresh titration regardless of your previous GLP-1 or dual-agonist experience.
Managing the 5mg Mounjaro to Wegovy transition involves monitoring for both discontinuation effects and new treatment adaptation during the changeover period. Some patients experience temporary appetite changes or digestive adjustments as their body adapts from tirzepatide's dual-receptor activation to semaglutide's GLP-1-focused mechanism. Our clinical team coordinates with your prescriber to ensure smooth transition timing, appropriate monitoring intervals, and responsive adjustment if any tolerability concerns arise during the switch. The goal is maintaining consistent weight management support whilst optimising your treatment regimen based on individual response patterns and lifestyle factors that influence long-term success.
Making Your 5mg Mounjaro to Wegovy Decision with Expert Support
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to expert comparison and ongoing supply regardless of which treatment your prescriber recommends. Our clinical assessment evaluates your individual circumstances, previous treatment response, and specific factors that might favour semaglutide over tirzepatide or vice versa. New customers can use discount code FIRST40 whilst existing patients apply DOSE25 at checkout to access our transparent pricing structure. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and receive personalised prescriber guidance on the most appropriate treatment option. Remember that weight management is a long-term commitment requiring ongoing medical supervision, lifestyle modifications, and consistent medication adherence to achieve and maintain clinically meaningful results. Your prescriber can help determine which prescription-only medicine aligns best with your individual treatment goals and circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
